Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey-Reference-Cited by-同舟云学术

Disease and treatment characteristics of polycythemia vera patients in Belgium: Results from a scientific survey

Published:2018-02-07 Issue:4 Volume:100 Page:361-366
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Devos Timothy¹²^ORCID,Beguin Yves³,Noens Lucien⁴,Van Eygen Koen⁵,Zachée Pierre⁶,Mineur Philippe⁷,Knoops Laurent⁸,Doyen Chantal⁹,Theunissen Koen¹⁰,Benghiat Fleur Samantha¹¹,Reusens Michael¹²^ORCID,Pluymers Wim¹²

Affiliation:

1. Department of Haematology; University Hospitals Leuven; Leuven Belgium

2. Department of Microbiology and Immunology; Laboratory of Experimental Transplantation; KU Leuven; Leuven Belgium

3. CHU de Liège; University of Liège; Liège Belgium

4. UZ Gent; Gent Belgium

5. AZ Groeninge; Kortrijk Belgium

6. ZNA; Antwerpen Belgium

7. Grand Hôpital de Charleroi; Charleroi Belgium

8. UCL Saint Luc; Bruxelles Belgium

9. CHU UCL Namur (Godinne); Université catholique de Louvain; Yvoir Belgium

10. Jessa Ziekenhuis; Hasselt Belgium

11. Hôpital Erasme; Bruxelles Belgium

12. Novartis Pharma NV/SA; Vilvoorde Belgium

Funder

Novartis

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13022/fullpdf

Reference30 articles.

1. Polycythemia vera;Landolfi;Intern Emerg Med,2010

2. Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options;Stein;Ann Hematol,2014

3. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs);Mesa;Cancer,2007

4. The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients;Scherber;Blood,2011

5. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study;Tefferi;Leukemia,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Clinical Characterisation of Polycythaemia Vera Patients from a Prospective Registry in Portugal: Is Resistance to Hydroxyurea a Reality?;Hematology Reports;2023-09-13

2. Real-world patient characteristics and treatment patterns of polycythemia vera in Taiwan between 2016 and 2017: a nationwide cross-sectional study;Therapeutic Advances in Hematology;2023-01

3. Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study;The Lancet Haematology;2022-07

4. Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythaemia Vera: a Multicentre Chart Review Study;Turkish Journal of Hematology;2020-02-20

5. Treatment strategies for polycythemia vera: Observations in a Dutch “real‐world” cohort study;European Journal of Haematology;2019-09-05